Royal Prince Alfred Hospital
Royal Prince Alfred Hospital
Infectious Diseases Department

About Us



Dr Raymond Chan, Head of Department

MBBS MPH PhD FRACP FRCPA FFSc FAICD
Raymond Chan graduated from the University of Sydney in 1985. He is a consultant physician in Infectious Disease (1992) and a Clinical Microbiologist (1995). Since completion of his training at RPA he worked at the John Hunter Hospital, Bankstown Hospital, and Liverpool Hospital before returning to RPA in 2007. He has broad interests in Infectious Disease. In Microbiology he is interested in diagnostic errors, laboratory quality and laboratory accreditation. He was an examiner in Microbiology for the Royal College of Pathologists of Australasia from 1996-2015. He is a Fellow of the Australian Institute of Company Directors.

He chairs the RPA Infection Prevention and Control Committee, the NSWHealth Pathology Microbiology Clinical Stream and the RCPA Quality Assurance Programs Pty Ltd Board of Directors. He is a member of the Clinical Advisory Board of Family Planning NSW and a member of the NATA Medical Testing Accreditation Advisory Committee.

 




Dr Rebecca Davis

BMBS, DTMH, FRACP, FRCPath (UK), FRCPA
Rebecca Davis is a consultant physician in Infectious Diseases (2004) and a Medical Microbiologist (2007). She graduated from Flinders University, South Australia and undertook infectious diseases and microbiology training in Adelaide, Darwin, Sydney, Oxford and London. She has an interest in infections in immunocompromised patients including those who have had solid organ transplants and is involved with Infection Prevention and Control in neonatal and elderly patients.




Dr Andie Lee

MB BS (Hons), DTM&H, MSc Epidemiology, FRACP, FRCPA
Andie Lee is a consultant Infectious Diseases Physician and Clinical Microbiologist (dual fellowship 2007). She graduated from the University of Sydney and is a Clinical Senior Lecturer at the University. After completing her specialty training in Australia, she spent 2.5 years as a Research Fellow at the University of Geneva Hospitals, Switzerland, working on a multicentre intervention study comparing strategies to control the spread of antibiotic resistant bacteria in hospitals in Europe and Israel. She has clinical and research interests in the prevention of healthcare associated infections, as well as clinical interests in tropical medicine and mycobacterial infections.





Dr Angie Pinto

MB BS, BSc, MPHTM, FRACP, FRCPA
Angie Pinto is a Staff Specialist in Infectious Diseases and Microbiology. She graduated from the University of New South Wales, and obtained her dual fellowships in 2012. She trained at Royal Prince Alfred Hospital, Concord Repatriation General Hospital, Westmead Hospital and St Vincent's Hospital in Sydney. She has broad interests including HIV, tropical medicine and antimicrobial resistance.  She divides her time between Royal Prince Alfred Hospital and The Kirby Institute.




A/Prof Sebastian van Hal

MBChB, FRACP, FRCPA, PhD

Sebastian van Hal obtained his medical degree from The University of Cape Town, South Africa, in 1995. After working extensively in Africa and Europe, he moved to Australia and completed his training in Infectious Diseases and Microbiology. He is a Staff Specialist at the Department of Microbiology and Infectious Diseases, Royal Prince Alfred Hospital and a Conjoint Associate Professor at the School of Medicine, University of Western Sydney.

He has published over a 100 peer reviewed papers focusing on the consequences and mechanisms of antibiotic resistance in Staphylococcus aureus and Enterococcus faecium. In 2014 he spent time at the Oxford Genomics Centre acquiring the skills required for translation of microbial genomics into hospital epidemiology and is responsible for this evolving service at RPAH.

He is also an active member of AGAR (Australian Group of Antimicrobial Resistance) and AURA (Antimicrobial Use and Resistance in Australia) and ANZMIG (Australian New Zealand Mycology Interest Group) which have led to several prominent publications including the development of the Antifungal Consensus guidelines.